MMedication Read More FDA upgrades recall for tens of thousands of bottles of commonly prescribed medication10 October 2025 CINCINNATI (WKRC) – The FDA upgraded a recall for a commonly prescribed medication that may pose a health…
MMedication Read More What It Means for Access8 October 2025 Shortly before the federal government shut down last week, officials at the Food and Drug Administration quietly approved…
NNutrition Read More FDA reverses NMN decision2 October 2025 Agency responds to petition by Natural Products Association and Alliance for Natural Health, allowing NMN as a dietary…
MMedication Read More Outside U.S., “Don’t Take Tylenol” Message Sharply Rebuked1 October 2025 Tylenol brand pain reliever (acetaminophen) is under fire by the Trump administration for possible links to autism. Photographer:…
HHealth Read More How switching your old lightbulbs for new LED lights increases your risk of diabetes, obesity and even dementia – as experts reveal disturbing link between modern lamps and disease23 September 2025 It sounds almost too good to be true, but researchers think that shining red light at patients could…
MMental health Read More San Antonio clinics use magnetic fields to treat major depression21 September 2025 San Antonio residents who suffer from depression have historically had access to two clinical treatment options: psychotherapy and…
HHealth Read More Experts warn against new celebrity-led trend for taking common medication to beat anxiety: ‘Raised risk of death’20 September 2025 Experts are warning people against taking the little blue pill celebrities promise will calm nervous jitters in all…
MMedication Read More FDA cracks down on prescription drug ads but lacks staff17 September 2025 WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
GGenetics Read More Saol Therapeutics hit with CRL for rare genetic disease11 September 2025 The U.S. FDA issued a complete response letter (CRL) for the NDA to privately held Saol Therapeutics Inc.’s…
MMedication Read More How a change in FDA guidance might revolutionise MASH drug development9 September 2025 Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…